Catalyst Pharmaceuticals
CPRX
#3622
Rank
HK$29.99 B
Marketcap
HK$245.13
Share price
0.03%
Change (1 day)
20.89%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: HK$29.99 Billion

As of June 2026 Catalyst Pharmaceuticals has a market cap of HK$29.99 Billion. This makes Catalyst Pharmaceuticals the world's 3622th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$29.99 B28.82%
2025HK$23.28 B17.13%
2024HK$19.88 B42.04%
2023HK$13.99 B-7.46%
2022HK$15.12 B178.18%
2021HK$5.43 B102.33%
2020HK$2.68 B-11.01%
2019HK$3.01 B95.49%
2018HK$1.54 B-50.66%
2017HK$3.13 B363.79%
2016HK$0.67 B-57.1%
2015HK$1.57 B-1.19%
2014HK$1.59 B94.53%
2013HK$0.81 B486.09%
2012HK$0.13 B-43.57%
2011HK$0.24 B65.63%
2010HK$0.14 B69.58%
2009HK$88.11 M-54.95%
2008HK$0.19 B-41.96%
2007HK$0.33 B-28.33%
2006HK$0.47 B

End of Day market cap according to different sources

On Jun 7th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

HK$29.98 Billion
by Nasdaq info icon info icon
HK$29.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.379 T 14,498.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.144 T 3,714.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.235 T 4,017.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$12.86 B-57.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.43 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$85.65 B 185.53%๐Ÿ‡บ๐Ÿ‡ธ USA